Anna Cichonska

Director of Data Science and Head of European Operations at Harmonic Discovery

Presenter

We are a biotechnology startup based in New York City and Helsinki, building advanced AI to design novel, best-in-class kinase inhibitors with optimal selectivity profiles. Our platform, which integrates generative AI, kinase modeling, and computational chemistry, has been experimentally validated and enables the rapid design and optimization of small molecules against challenging target profiles. We are advancing multiple internal programs in malignant and benign hematology towards the clinic.